These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27686591)

  • 21. Management of parotid duct injuries.
    Steinberg MJ; Herréra AF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Feb; 99(2):136-41. PubMed ID: 15660081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Volumetric and dosimetric changes to salivary glands during radiotherapy for head and neck cancer.
    Najim M; Perera L; Bendall L; Sykes JR; Gebski V; Cross S; Veness M
    Acta Oncol; 2015; 54(9):1691-3. PubMed ID: 26219957
    [No Abstract]   [Full Text] [Related]  

  • 23. CT-based parotid gland location: implications for preservation of parotid function.
    Roesink JM; Terhaard CH; Moerland MA; van Iersel F; Battermann JJ
    Radiother Oncol; 2000 May; 55(2):131-3. PubMed ID: 10799724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
    Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of weight loss in patients with head and neck carcinoma undergoing radiotherapy: is it an underestimated phenomenon? A radiation oncologist's perspective.
    Cacicedo J; Dal Pra A; Alongi F; Navarro A
    Eur J Clin Nutr; 2015 Jul; 69(7):757-60. PubMed ID: 25920425
    [No Abstract]   [Full Text] [Related]  

  • 26. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
    Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
    Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration.
    Lee C; Langen KM; Lu W; Haimerl J; Schnarr E; Ruchala KJ; Olivera GH; Meeks SL; Kupelian PA; Shellenberger TD; Mañon RR
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1563-71. PubMed ID: 18538505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDG-PET assessment of the effect of head and neck radiotherapy on parotid gland glucose metabolism.
    Roach MC; Turkington TG; Higgins KA; Hawk TC; Hoang JK; Brizel DM
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):321-6. PubMed ID: 21030160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR sialography: the effect of a sialogogue and ductal occlusion in volunteers.
    Hugill J; Sala E; Hollingsworth KG; Lomas DJ
    Br J Radiol; 2008 Jul; 81(967):583-6. PubMed ID: 18443015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer.
    van Luijk P; Pringle S; Deasy JO; Moiseenko VV; Faber H; Hovan A; Baanstra M; van der Laan HP; Kierkels RG; van der Schaaf A; Witjes MJ; Schippers JM; Brandenburg S; Langendijk JA; Wu J; Coppes RP
    Sci Transl Med; 2015 Sep; 7(305):305ra147. PubMed ID: 26378247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salivary duct carcinoma of the accessory parotid gland.
    Funamura JL; Aouad RK; Ramsamooj R; Donald PJ
    Otolaryngol Head Neck Surg; 2013 Aug; 149(2):347-8. PubMed ID: 23652666
    [No Abstract]   [Full Text] [Related]  

  • 32. Parotid sparing study in head and neck cancer patients receiving bilateral radiation therapy: one-year results.
    Ship JA; Eisbruch A; D'Hondt E; Jones RE
    J Dent Res; 1997 Mar; 76(3):807-13. PubMed ID: 9109831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simple tool for prediction of parotid gland sparing in intensity-modulated radiation therapy.
    Gensheimer MF; Hummel-Kramer SM; Cain D; Quang TS
    Med Dosim; 2015; 40(3):232-4. PubMed ID: 25704638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Normal tissue tolerance to external beam radiation therapy: salivary glands].
    Ortholan C; Benezery K; Bensadoun RJ
    Cancer Radiother; 2010 Jul; 14(4-5):290-4. PubMed ID: 20609609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In regard to Münter et Al. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without amifostine. (Int j radiat oncol biol phys 2007;67:651-659).
    Messerschmidt GL; Oleka N
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1651-2; author reply 1652. PubMed ID: 18035221
    [No Abstract]   [Full Text] [Related]  

  • 36. A quantitative assessment of volumetric and anatomic changes of the parotid gland during intensity-modulated radiotherapy for head and neck cancer using serial computed tomography.
    Ajani AA; Qureshi MM; Kovalchuk N; Orlina L; Sakai O; Truong MT
    Med Dosim; 2013; 38(3):238-42. PubMed ID: 23558146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parotid gland sparing with helical tomotherapy in head-and-neck cancer.
    Voordeckers M; Farrag A; Everaert H; Tournel K; Storme G; Verellen D; De Ridder M
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):443-8. PubMed ID: 22836056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation-induced damage to microstructure of parotid gland: evaluation using high-resolution magnetic resonance imaging.
    Kan T; Kodani K; Michimoto K; Fujii S; Ogawa T
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1030-8. PubMed ID: 19879064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials.
    Roesink JM; Schipper M; Busschers W; Raaijmakers CP; Terhaard CH
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1006-9. PubMed ID: 15964708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What lies beneath.
    Jones D
    Dermatol Surg; 2011 Mar; 37(3):387-8. PubMed ID: 21410821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.